Suppr超能文献

两亲性二硫代氨基甲酸盐对镉预暴露大鼠细胞内镉动员及肝脏和肾脏金属硫蛋白调节的功效。

Efficacy of amphipathic dithiocarbamates in intracellular cadmium mobilization and in modulation of hepatic and renal metallothionein in cadmium pre-exposed rat.

作者信息

Tandon S K, Prasad S, Singh S, Agarwal D K

机构信息

Chelation Therapy Section, Industrial Toxicology Research Centre, Lucknow, India.

出版信息

Chem Biol Interact. 1998 Jul 24;114(3):161-75. doi: 10.1016/s0009-2797(98)00043-x.

Abstract

Forty-eight hours after an intraperitoneal injection of cadmium chloride (1.5 mg Cd/kg) to female albino rats, Cd was mainly localized in the hepatic and renal supernatant cytosolic fraction (SCF). Seventy-two hours later, the total hepatic burden remained unchanged but the total renal burden was enhanced, showing its tendency to accumulate in the kidney. A single dose (0.4 mmol/kg, i.p.) of sodium N-benzyl-D-glucamine dithiocarbamate (BG.DTC) or sodium N-(4-methoxybenzyl)-D-glucamine dithiocarbamate (MeO.BG.DTC), 24 h after Cd injection, efficiently mobilized Cd from hepatic SCF, apparently from cadmium-metallothionein (Cd-MT); MeO.BG.DTC also removed Cd from hepatic nuclear mitochondrial fraction. This treatment, however, increased the renal burden of Cd, indicating that the chelating agents, at least partly, transport Cd from the liver and possibly from other sites into the kidney. Three doses of the chelators further enhanced mobilization of Cd from hepatic as well as renal SCF, as corroborated by its enhanced urinary and, to a greater extent, fecal excretion. Hepatic and renal MT were induced several-fold above normal after a single dose of Cd as well as single or repeated doses of BG.DTC or MeO.BG.DTC. Seventy-two hours after a Cd injection, the hepatic MT declined to half of the induced level while the renal MT remained elevated. Administration of BG.DTC or MeO.BG.DTC in Cd pre-treated rats produced an additive response in hepatic MT, but the response in renal MT was less than additive at one dose and slightly declined after three doses. Hepatic Zn and Cu and renal Zn increased on treatment with Cd but were depleted after a single or repeated injection of BG.DTC or MeO.BG.DTC in normal as well as in Cd pre-exposed animals. The results indicate that intracellular access of amphipathic dithiocarbamates effectively mobilizes MT-bound Cd, which is preferentially excreted in the feces, and helps avoid further burden on the kidney and consequent nephrotoxicity. Additionally, MeO.BG.DTC was a better inducer of hepatic MT to help increased capture of toxic metal from the initial circulation and consequent toxicity.

摘要

给雌性白化大鼠腹腔注射氯化镉(1.5毫克镉/千克)48小时后,镉主要定位于肝脏和肾脏的上清液胞质部分(SCF)。72小时后,肝脏中的总镉含量保持不变,但肾脏中的总镉含量增加,表明镉有在肾脏中蓄积的趋势。在注射镉24小时后,单次腹腔注射剂量为0.4毫摩尔/千克的N-苄基-D-葡糖胺二硫代甲酸盐(BG.DTC)或N-(4-甲氧基苄基)-D-葡糖胺二硫代甲酸盐(MeO.BG.DTC),能有效地从肝脏SCF中动员镉,显然是从镉-金属硫蛋白(Cd-MT)中动员出来;MeO.BG.DTC还能从肝脏核线粒体部分去除镉。然而,这种处理增加了肾脏中的镉含量,表明螯合剂至少部分地将镉从肝脏以及可能从其他部位转运到了肾脏。三剂螯合剂进一步增强了从肝脏和肾脏SCF中动员镉的能力,这一点通过尿镉排泄增加以及在更大程度上通过粪镉排泄增加得到了证实。单次注射镉以及单次或重复注射BG.DTC或MeO.BG.DTC后,肝脏和肾脏中的金属硫蛋白(MT)诱导水平比正常水平高出几倍。注射镉72小时后,肝脏中的MT降至诱导水平的一半,而肾脏中的MT仍保持升高。在镉预处理的大鼠中给予BG.DTC或MeO.BG.DTC,肝脏MT产生相加反应,但肾脏MT在一剂时的反应小于相加,三剂后略有下降。用镉处理后,肝脏中的锌、铜以及肾脏中的锌含量增加,但在正常动物以及预先接触过镉的动物中,单次或重复注射BG.DTC或MeO.BG.DTC后这些元素会减少。结果表明,两亲性二硫代甲酸盐进入细胞内可有效动员与MT结合的镉,镉优先通过粪便排出,有助于避免肾脏进一步负担及随之而来的肾毒性。此外,MeO.BG.DTC是肝脏MT更好的诱导剂,有助于从初始循环中增加对有毒金属的捕获及随之而来的毒性作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验